Burke & Herbert Bank & Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.05M Sell
20,061
-2,747
-12% -$591K 1.25% 16
2026
Q1
$4.96M Buy
22,808
+935
+4% +$207K 1.37% 14
2025
Q4
$5M Sell
21,873
-436
-2% -$99.3K 1.38% 14
2025
Q3
$5.17M Sell
22,309
-310
-1% -$63.1K 1.11% 19
2025
Q2
$4.2M Buy
22,619
+632
+3% +$117K 0.94% 23
2025
Q1
$4.61M Buy
21,987
+1,300
+6% +$253K 1.11% 19
2024
Q4
$3.68M Hold
20,687
0.87% 26
2024
Q3
$4.09M Sell
20,687
-812
-4% -$152K 0.95% 20
2024
Q2
$3.69M Buy
21,499
+10,017
+87% +$1.66M 0.9% 23
2024
Q1
$2.09M Sell
11,482
-45
-0.4% -$7.75K 1.57% 14
2023
Q4
$1.79M Sell
11,527
-1
-0% -$146 1.28% 20
2023
Q3
$1.72M Sell
11,528
-582
-5% -$85.4K 1.39% 19
2023
Q2
$1.63M Sell
12,110
-145
-1% -$21.3K 1.1% 22
2023
Q1
$1.95M Sell
12,255
-258
-2% -$39.4K 1.44% 17
2022
Q4
$2.02M Sell
12,513
-150
-1% -$23K 1.5% 16
2022
Q3
$1.7M Sell
12,663
-10
-0.1% -$1.44K 1.41% 14
2022
Q2
$1.94M Sell
12,673
-348
-3% -$53.2K 1.46% 15
2022
Q1
$2.11M Sell
13,021
-611
-4% -$88.8K 1.34% 17
2021
Q4
$1.85M Buy
13,632
+44
+0.3% +$5.2K 1.08% 27
2021
Q3
$1.47M Buy
13,588
+28
+0.2% +$3.2K 0.95% 33
2021
Q2
$1.53M Sell
13,560
-49
-0.4% -$5.52K 0.98% 30
2021
Q1
$1.47M Sell
13,609
-1,513
-10% -$162K 1.01% 30
2020
Q4
$1.62M Sell
15,122
-224
-1% -$21.5K 1.15% 21
2020
Q3
$1.34M Sell
15,346
-56
-0.4% -$5.27K 1.06% 26
2020
Q2
$1.51M Buy
15,402
+155
+1% +$13.6K 1.31% 18
2020
Q1
$1.16M Sell
15,247
-158
-1% -$13.5K 1.18% 24
2019
Q4
$1.36M Buy
15,405
+1,186
+8% +$98.5K 1.05% 27
2019
Q3
$1.08M Sell
14,219
-21
-0.1% -$1.44K 0.95% 32
2019
Q2
$1.03M Sell
14,240
-189
-1% -$14.9K 0.91% 33
2019
Q1
$1.16M Sell
14,429
-139
-1% -$11.4K 1.03% 30
2018
Q4
$1.34M Sell
14,568
-82
-0.6% -$7.21K 1.32% 19
2018
Q3
$1.39M Sell
14,650
-11
-0.1% -$1.04K 1.18% 23
2018
Q2
$1.36M Buy
14,661
+490
+3% +$47.9K 1.22% 22
2018
Q1
$1.34M Sell
14,171
-40
-0.3% -$4.39K 1.21% 23
2017
Q4
$1.37M Sell
14,211
-60
-0.4% -$5.66K 1.18% 26
2017
Q3
$1.27M Sell
14,271
-535
-4% -$40.7K 1.15% 29
2017
Q2
$1.07M Sell
14,806
-623
-4% -$41.9K 0.98% 32
2017
Q1
$1M Buy
15,429
+412
+3% +$25.9K 0.9% 33
2016
Q4
$941K Hold
15,017
0.85% 37
2016
Q3
$947K Buy
15,017
+789
+6% +$51.1K 0.86% 34
2016
Q2
$881K Sell
14,228
-145
-1% -$8.84K 0.8% 34
2016
Q1
$821K Sell
14,373
-141
-1% -$7.86K 0.79% 35
2015
Q4
$860K Sell
14,514
-310
-2% -$17.9K 0.9% 34
2015
Q3
$807K Sell
14,824
-451
-3% -$29.4K 0.91% 34
2015
Q2
$1.03M Sell
15,275
-1,025
-6% -$66.9K 1.09% 29
2015
Q1
$954K Sell
16,300
-1,075
-6% -$64.9K 1.04% 32
2014
Q4
$1.14M Sell
17,375
-50
-0.3% -$3.15K 1.14% 24
2014
Q3
$1.01M Sell
17,425
-1,200
-6% -$66.6K 0.98% 28
2014
Q2
$1.05M Sell
18,625
-500
-3% -$26.2K 0.96% 27
2014
Q1
$983K Sell
19,125
-450
-2% -$22.7K 0.97% 28
2013
Q4
$1.03M Hold
19,575
1.03% 24
2013
Q3
$875K Sell
19,575
-360
-2% -$16K 0.98% 27
2013
Q2
$825K Buy
+19,935
New +$872K 0.96% 27

Other funds holding ABBV

Burke & Herbert Bank & Trust's ABBV Position: Q2 2026 in Review

Burke & Herbert Bank & Trust reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $591K and leaving 20,061 shares worth $5.05M. The position accounts for 1.25% of the portfolio, ranked #16.

Burke & Herbert Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.17M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Burke & Herbert Bank & Trust held 20,061 shares of AbbVie worth $5.05M as of Q2 2026.
  • Burke & Herbert Bank & Trust sold 2,747 AbbVie shares in Q2 2026, an estimated $591K.
  • AbbVie made up 1.25% of Burke & Herbert Bank & Trust's portfolio in Q2 2026, its #16 holding.
  • Burke & Herbert Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Burke & Herbert Bank & Trust's AbbVie position peaked at $5.17M in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Burke & Herbert Bank & Trust's 13F filing for Q2 2026, filed 7 Aug 2026.